(GDP) ranks 15th in the world in 2011. Stroke research in Korea has also achieved great advances. The annual growth of clinical and epidemiological stroke articles of Korea was more than twice the worldwide average, and for the quantity of articles Korea was ranked on the 8th position worldwide, 2nd position after Japan among Asian countries. 2 However, despite these achievements, a representative summary of stroke statistics in Korea has not been formally published. As a result, establishing an efficient health care plan and guiding future research directions to reduce the burden of stroke in Korea lack firm scientific underpinning. Accordingly, the Korean Stroke Society (http:// www.stroke.or.kr/) and the Clinical Research Center for Stroke (http://www.stroke-crc.or.kr/) decided to summarize nationally representative data on stroke and to present them in a single document of Stroke Statistics in Korea. The current report focuses on stroke epidemiology and risk factors, and data of acute stroke management will be presented in another future report. For the current report, we searched the most representative national data from reports of the Korean government or related organizations and published articles. When representative national data are not available, we present the most relevant data of hospital-based studies from a literature review, recognizing the limitations. If there are discrepancies in data across reports, we adopt data of original reports rather than summary reports. The current report of Stroke Statistics in Korea would be a valuable resource for healthcare providers, researchers, policy makers, and the public who seek the best national data on stroke.
Stroke incidence
Each year, about 105,000 Korean people experience a new or recurrent stroke. On average, every 5 minutes stroke attacks someone in Korea. The stroke incidence was adopted from the 2006 report of the Construction of National Surveillance System for Cardiovascular and Cerebrovascular Diseases, which analyzed the 2004 in-surance claim database of the Korean Health Insurance Review Agency and national death certificate data to estimate the nationwide stroke incidence in Korea. 3 In that study, the stroke diagnosis of the insurance claim data was certified from the review of individual cases for a representative sample, using a diagnostic algorithm combining clinical and imaging data. According to a nation-wide hospital-based stroke registry study, one in five ischemic strokes or TIAs was a recurrent stroke. 4 The estimated incidence is 216 per 100,000 person-years. The age-specific stroke incidence is presented in Figure 1 . With increasing age, the incidence per 100,000 person-years steeply increased from 20 in population aged ≤ 44 years to 3,297 in those aged ≥ 85 years. The overall incidence was greater in women (220/100,000 person-years) than in men (213/100,000 person-years). However, when stratified by age group, the incidence was greater in men than in women across all age groups ( Figure 2 ). The discrepancy is attributed to more elderly population in women than in men. 3 Stroke in the population aged 65-74 accounted for more than 30% of all strokes. When stratified by sex, the 65-74 age group accounted for the largest proportion in men, whereas the age group of 75-84 years accounted for the largest proportion in women ( Figure 3 ). For ischemic stroke and unclassified stroke, the relative contribution of each age group was generally consistent with the findings of all strokes (Figures 4 and 5 ). In contrast, the contribution of younger age groups for hemorrhagic stroke was greater than for ischemic stroke, and hemorrhagic stroke in the population under 55 years of age accounted for Sex-and age-specific stroke incidence 26 41.2% in men and 27.3% in women of all hemorrhagic strokes ( Figure 6 ). By 2030, the annual stroke incidence in Korea is estimated to rise up to 350,000 due to a rapid increase in elderly population. 5 Stroke incidence data from prospective cohort studies of representative populations are not available in Korea, and future research is needed.
Ischemic stroke and hemorrhagic stroke
According to an estimation from the database of Korean Health Insurance Review Agency during the period from 1995 to 2003, the age-standardized incidence of ischemic stroke in the population 35-74 years of age increased annually by 7.18%, whereas hemorrhagic stroke decreased annually by 1.82% and unclassified stroke by 9.21%. As a result, the proportion of ischemic strokes among all strokes increased from 43% in 1995 to 65.2% in 2003 (Figure 7 ). 6 For stroke admission as a primary diagnostic code (ICD-10 code: hemorrhagic stroke for I60-62, ischemic stroke for I63) during 2001 to 2009, admission for hemorrhagic stroke remained stable, but admission for ischemic stroke increased substantially ( Figure 8) . Therefore, the proportion of ischemic stroke admissions increased from 64.7% in 2000 to 76.1% in 2009 ( Figure 9 ). Among hemorrhagic stroke admissions, the ratio of intracerebral hemorrhage to subarachnoid hemorrhage remained stable, ranging between 2.3 and 2.6.
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Ischemic stroke subtype Data of ischemic stroke subtype from population-based studies are not available. According to a nationwide hospital-based stroke registry study which evaluated the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification 11 for 36,191 ischemic strokes between 2002 and 2010, large artery atherosclerosis (LAA, 36.1%) was the most common type, followed by small vessel occlusion (SVO, 25.4%) and cardioembolism (CE 17.1%). Over the nine years, the relative proportion of cardioembolism increased, large artery atherosclerosis remained stable, and small vessel occlusion and stroke due to undetermined etiology decreased. 4 That study did not include patients who were admitted to non-neurology departments or who arrived at the emergency department but were not hospitalized. However, data of the excluded patients are unlikely to substantially change the study findings.
Stroke prevalence
An estimated 795,000 Koreans ≥ 30 years of age had a stroke diagnosed by physicians (extrapolation of prevalence data of the 2005 Korean National Health and Nutrition Examination Survey [KNHANES] 12 to 2012 population provided by Korean Statistical Information Service 5 ). The KNHANES is a crosssectional survey to assess the health and nutritional status of adults and children in Korea, using interviews and examinations for a representative national sample of the Korean population selected from a complex, stratified, multistage probability cluster sampling design. The age-standardized stroke prevalence in population ≥ 30 years of age is estimated to be 1.59% (data of KNHANES 2005). For each sex, roughly 411,000 Korean men (1.64%) and 384,000 (1.54%) Korean women have had a stroke.
Stroke prevalence steeply increases with age. The 2005 KNHANES data demonstrated that the prevalence increased from 0.14% in the 30-39 years old population to 6.75% in those ≥ 70 years of age ( Figure 10) . 12 Another study also showed that the estimated stroke prevalence increased from 0.15% for men and 0.09% for women in the population aged ≤45 years to 7.21% for men and 4.98% for women ≥ 85 years of age ( Figure 11 ). 3 According to the 2010 KNHANES data, the prevalence of stroke diagnosed by physicians was 2.9% (3.7% for men, 2.3% for women) for the population ≥ 50 years of age and 4.5% (5.6% for men, 3.7% for women) for those ≥ 65 years. However, there is a substantial variation in the prevalence data between 1998 and 2010, suggesting limitations of the survey studies in the accuracy of diagnostic criteria (Figure 12 ). 13 The KNHANES 2010 report showed that the lower income population had a higher stroke prevalence than high income population in both men and women during 1998-2010 ( Figure  13 ). The difference in stroke prevalence between low income and high income populations was generally greater in men than in women (Figures 14 and 15 ).
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Stroke mortality
In 2010, stroke killed 26,517 Korean people. Stroke is the Low Low to middle Middle to high High stroke mortality rate in 2010 was 53.2 per 100,000 (51.5/100,000 for men and 54.8/100,000 for women) ( Figure 16 ). [14] [15] [16] More women than men die of stroke.
From 2001 to 2010, the age-standardized stroke death rate decreased by 28.3% (27.9% for men and 28.9% for women) ( Figure 16 ), and the actual number of stroke deaths declined by 25.4% ( Figure 17 ). During that period, the contribution of stroke deaths to all deaths decreased from 14.7% to 10.4% (from 12.8 % to 9.0% for men and from 17.1% to 12.1% for women) ( Figure 18 ). [14] [15] [16] Over the 10 years, women had a higher stroke mortality rate than men, and there was no substantial change in women-to-men ratio (from 1.08 to 1.06). [14] [15] [16] Stroke mortality rates steeply increased with age, particularly after age 70. Compared to the population 60-69 years of age, stroke mortality rate increased by 4-fold in those 70-79 years of age and by 13-fold in those ≥ 80 years of age ( Figure 19 ). 14 In Korea, age-standardized stroke mortality rate has a geographic disparity (range, 27.5/100,000 to 47.8/100,000). In 2010, Jeollabuk-do, the southwest province (47.8/100,000), and Gangwon-do, the northeast province (47.4/100,000) rank- ed No. 1 and No. 2, and Jeju island had the lowest stroke mortality rate (27.5/100,000) followed by Seoul (34.8/100,000) ( Figure 20 ). 14 The average age-standardized mortality rate did not differ between metropoiltan cities and the other regions (42.5/100,000 vs 42.4/100,000).
30-day case-fatality rate of stroke
Stroke 30-day case-fatality rate usually indicates the proportion of deaths within 30 days after the index stroke. The Korean Center for Disease Control reported that the 30-day case-fatality rate was 23.9% (95% confidence interval, 22.2-25.8%) in 2004. 3 Compared to ischemic stroke, hemorrhagic stroke caused a 2.4-fold higher case-fatality rate (35.0% vs. 15.2%). Women had a higher case-fatality rate for any stroke and ischemic stroke than men, whereas the hemorrhagic stroke case-fatality rate was slightly higher in men than in women ( Figure 21 ). For any stroke and ischemic stroke, with increasing age, the 30-day case-fatality rate generally increased in both men and women (Figures 22  and 23) . However, the case-fatality rate for hemorrhagic stroke showed a complex pattern of a relatively high 30-day case-fatality rate in younger age groups ( Figure 24 ). In contrast, the Korean Stroke Registry Study in which 31 centers nationwide prospectively enrolled 46,098 patients with ischemic stroke from 2002 to 2010 showed that the average 30-day case-fatality rate of ischemic stroke was 4%. During the period, the age-adjusted 30-day case fatality rate did not decline, but the age-adjusted 1-year mortality rate did decline significantly. 4 The discrepancy in the 30-day case-fatality rate across the studies might attribute to differences in population, method, and time period, and further studies are needed to assess the current trend of 30-day stroke case-fatality rate.
In-hospital mortality rate
Acute stroke treatment has advanced dramatically over the last decade, and quality of stroke care in Korean hospitals has substantially improved. The Health Care Quality Indicators Project data demonstrated that, among OECD countries, Korea had the lowest in-hospital 30-day case-fatality rate for ischemic stroke (crude rate, 2.5%; age-sex standardized rate, 1.8%) and ranked third lowest for hemorrhagic stroke (crude rate, 10.2%; age-sex standardized rate, 9.8%) in 2009 (Figures 25  and 26) . 17 Although the analysis did not adjust for stroke severity, the single most important determinant of outcome, these findings suggest that hospitals in Korea are providing a high quality of acute stroke care.
According to the Report of Assessment for Quality of Acute Stroke Care in Korea 2010, the crude in-hospital mortality rate of acute stroke admission was 8.3% for any strokes, 4.3% for ischemic strokes, and 17.5% for hemorrhagic stroke. The crude mortality rates were stable during the period of 2005-2010 ( Figure 27 ). 
90-day functional outcome after stroke
Since stroke disables as well as kills people, disability after stroke is an important burden to patients, their family, and society. Therefore, measuring burden of stroke should incorporate the post-stroke disability as well as mortality. Since more than 90% of stroke recovery occurs in the first 3 months in most stroke patients, 18 residual post-stroke disability is usually assessed at 90 days after stroke. For a disability outcome measure, modified Rankin Scale (mRS) is most widely favored and recommended by researchers and regulatory authorities. 19, 20 For a nationwide representative population cohort, fine-grained 90-day mRS disability after stroke has not been evaluated in Korea as well as in most other countries, but several hospitalbased registry studies have reported 90-day mRS disability outcome. For ischemic stroke, 49-66% of patients had an excellent outcome of mRS 0-1 and 63-80% had a good outcome of mRS 0-2. Mortality rates at 90 days ranged 3-7% across the studies. [21] [22] [23] For hemorrhagic stroke, a single center study reported 3-month mRS outcome for 585 primary intracerebral hemorrhage. 24 As expected, hemorrhagic strokes had worse 90-day outcomes than ischemic strokes. Twenty-nine % of patients achieved independent outcome of mRS 0-3, and 16.9% were dead at 90 days.
Disability-adjusted life years (DALY) lost due to stroke
The DALY is a formal metric of the World Health Organization Global Burden of Disease Project (WHO-GBDP) to measure regional and global burdens of hundreds of diseases. The DALY incorporates disability and mortality into a single metric of healthy life years lost, whereby one DALY lost indicates one Any stroke Ischemic stroke Hemorrhagic stroke year loss of healthy life, free of disability. 25 In high income countries, the DALY lost to ischemic heart disease is usually greater than the DALY lost to stroke. However, among high income countries, Korea ranked No. 1 of greater DALY lost to stroke than to ischemic heart disease. 26 In the WHO-GBDP report, Korea is categorized into a group wherein the DALY lost to stroke is between 641 and 880 per 100,000 person-years. More specifically, the sex-and age-adjusted DALY lost per 100,000-years was 703, and the unadjusted DALY lost was 855 (obtained from a personal communication with S. Claiborne Johnston, who is the first author of a related article 27 ). Therefore, nationwide annual DALY lost to stroke would be about 344,000.
For ischemic stroke, the projected nationwide DALY lost due to 64,688 ischemic strokes in 2004 was 234,399 (121,482 for men and 113,244 for women), and the DALY lost per 100,000 person-years was 483 (500 for men and 469 for women). The DALY lost of 65-74 years contributed 37.9% to overall DALY lost, followed by the age groups of 75-84 and 55-64 years. For each stroke admission, the average costs in 2009 were 4.92 million KRW for any stroke, 3.95 million KRW for ischemic stroke, and 7.82 million KRW for hemorrhagic stroke, which gradually increased during the period of 2005-2009 (Figure 29) . Compared with an ischemic stroke admission, a hemorrhagic stroke admission carries a 2-fold greater cost. [7] [8] [9] The average lifetime cost for men who had a first stroke was estimated to be 200.7 million KRW at age 45, 81.9 million KRW at age 55, and 16.4 million KRW at age 65. For women, it was estimated to be 75.7 million KRW at age 45, 39.2 million KRW at age 55, and 19.3 million KRW at age 65. While strokes in those 45-64 years of age accounted for only 30% of all strokes, this age group incurred 75% of the total national lifetime costs of stroke. 30 However, the study might underestimate the lifetime cost since it did not consider the productivity loss of housewives and loss due to disability.
Risk factors
Hypertension Hypertension (HT) is the most important well-documented and modifiable risk factor for stroke. For blood pressure over 115/75 mm Hg, an increase in systolic blood pressure (SBP) of 20 mmHg or in diastolic blood pressure (DBP) of 10 mmHg was associated with a more than 2-fold increased risk of stroke mortality. 31 In a meta-analysis of clinical trials, antihypertensive treatment reduced the risk of stroke by 32% (95% CI, 24-36%). 32 
Prevalence
HT is defined as SBP ≥ 140 mm Hg or DBP ≥ 90 mm Hg or (Figure 30 ). 13 Data from NHANES 2010 showed that 28.9% of people aged ≥ 30 years had HT. HT was more prevalent in men than in women in those ≥ 30 years of age (30.1% vs. 27.7%). Until 59 years of age, a higher percentage of men than women have HT, but from 60 years of age HT was more prevalent in women than in men ( Figure 31) . 13 In the population < 50 years of age, men had twice the prevalence of HT than women.
Data from NHANES 2010 showed that the prevalence of HT in men increased until 60-69 years and then slightly decreas ed, and the HT prevalence in women monotonically increased with age. In men of 30-59 years, the prevalence of HT almost doubled with every 10-year increase of age. In women 30-69 years of age, the HT prevalence increased by nearly 10-fold from 30-39 years to 40-49 years, by almost 3-fold from 40-49 years to 50-59 years, and by a 1.7-fold from 50-59 years to 60-69 years ( Figure 31 ). Compared to worldwide prevalence data, 33 the HT prevalence in Korea is lower in men 30-49 years old and ≥ 70 years and in women aged 30-59 years and ≥ 70 years, but higher in men 50-69 years old and in women of 60-69 years.
Blood pressure
Data from KNHANES 2010 showed that with increasing age, SBP increased monotonically, and DBP increased until 60 years and then decreased in both men and women. For people of age less than 60 years, men had a higher SBP than women, but from age 60 SBP was higher in women than in men. DBP had a similar trend ( Figure 32 ). 13 
Awareness, treatment, and control
Data from KNHANES 2008-2010 showed that among people aged ≥ 30 years with hypertension, 67.9% were aware of their HT (diagnosed by physicians), 61.9% were on regular treatment (taking medication ≥ 20 days per month), and 43.6% had their blood pressure under control (SBP < 140 mmHg and DBP was < 90 mmHg). 13 The awareness, treatment, and control of HT improved compared to data of KNHANES 2007-2009 (Figure 33) , 34 but still remained less than those of the US population. 35 Women had higher percentages of awareness, treatment, and control of HT than men for all age groups. Younger age groups showed lower percentages of awareness, treatment, and control of HT than elderly groups. In people 30-39 years of age, less than 30% were aware of their HT, less than 20% had regular treatment, and about one of ten had their blood pressure under control ( Figure 34 ). (Figure 35) . 13 The smoking prevalence from KNHANES 2010 data (48.1% in men and 6.1% in women) was substantially higher in men and substantially lower in women compared to the US population (21.2% in US men and 17.5% in US women). 35 Data from KNHANES 2010 showed that the smoking prevalence in men was highest in 30-39 years of age (60.9%) and then decreased with age. However, more than half of men 19-59 years of age were still smoking ( Figure 36 ). 13 
Secondhand smoke
Secondhand smoke also increases the risk of stroke. In KN-HANES 2010, secondhand smoke was defined as inhalation of smoke in home or office by persons other than intended active smokers. From 2005 to 2010, the percentage of secondhand smoke slightly increased from 36.4% to 39.7%. 13 
Diabetes mellitus
People with diabetes mellitus (DM) have an increased risk of stroke. In patients with type 2 diabetes, each 1% increase in HbA1c was associated with a 12% increase of relative risk of stroke. 36 
Prevalence
In KNHANES 2010, DM was defined as fasting glucose ≥126 mg/d, diagnosis by physicians, or being treated with oral hypoglycemic agents or insulin.
One in ten Korean adults ≥ 30 years of age have DM, and A w a r e n e s s A w a r e n e s s A w a r e n e s s T r e a tm e n t T r e a tm e n t T r e a tm e n t . 13 The age-standardized prevalence of DM increased from 8.6% in 2001 to 9.7% in 2010, and the increase was greater in men (from 9.5% in 2001 to 11.0% in 2010) than in women (from 7.9% in 2001 to 8.3% in 2010) (Figure 37 ). 13 Data from KNHANES 2010 showed that 10.1% of population ≥ 30 years of age had DM. DM was more prevalent in men than in women (11.3% vs. 9.0%). Except for those 60-69 years of age, the prevalence of DM was higher in men than in women (Figure 38) . 13 Notably, in those 50-59 years of age, men had twice the prevalence of DM than women.
Data from KNHANES 2010 showed that the prevalence of DM in men increased until age 59, then slightly decreased in those aged 60-69 years, and then increased again after age 70. In contrast, in women, the prevalence of DM monotonically increased with aging. The steepest increase of DM prevalence was observed in 50-59 years for men and 60-69 years for women.
Blood glucose
According to data from KNHANES 2010, blood glucose level generally increased with aging. In women, as age increased, blood glucose level increased monotonically whereas in men blood glucose level increased until 50-59 years of age and then decreased after 60 years. In those less than 70 years old, men had a higher blood glucose level than women, but from age 70 blood glucose level was higher in women than in men ( Figure  39) .
Awareness, treatment, and control
Data from KNHANES 2008-2010 showed that of people with DM ≥ 30 years old, 73.0% were aware of their DM (diagnosed by physicians), 59.1% were on regular treatment (treatment with oral hypoglycemic agents or insulin), and 28.1% had their DM under control (HbA1c<6.5%). 13 The awareness, treatment, and control of DM were comparable to data of KN HA-NES 2007-2009 ( Figure 40 ). 34 Data from KNHANES 2010 showed that the percentages of awareness and treatment were higher in women than in men (awareness, 77.6% vs. 69.0%; treatment, 64.0% vs. 54.9%), but the percentage of control was higher in men than in women (30.1% vs. 25.8%). In men, younger age groups, particularly those 30-39 years of age, showed substantially low percentages of awareness, treatment, and control. In women, the percentage of awareness was generally high for all age groups. However, in young women, the percentages of treatment and control were very low given their high percentage of awareness ( Figure 41 ).
Dyslipidemia
Despite the inconsistent epidemiological findings of the association between hypercholesterolemia and stroke, lowering cholesterol with statins reduces the risk of ischemic stroke in patients with high risk for stroke or with non-cardioembolic 37 
Prevalence
In KNHANES 2010, hypercholesterolemia was defined as total cholesterol ≥ 240 mg/dL or taking cholesterol lowering medication, low HDL-cholesterol as < 40 mg/dL, and hypertriglyceridemia as ≥ 200 mg/dL.
Among Korean adults ≥ 30 years of age, one in seven has hypercholesterolemia, one in four has low HDL-cholesterol, and one in six has hypertriglyceridemia. Approximately 3,800,000 adults ≥ 30 years of age have hypercholesterolemia, about 7,400,000 have low-HDL, and 4,700,000 have hypertriglyceridemia (data from 2010 KNHANES adjusted to 2005 standardized population). 13 The age-standardized prevalence of hypercholesterolemia increased from 10.0% in 1998 to 13.5% in 2010, and the increase was greater in men (from 8.7% in 1998 to 13.0% in 2010) than in women (from 10.6% in 1998 to 13.4% in 2010). The age-standardized prevalence of hypertriglyceridemia increased during 1998 to 2001 and then remained stable since 2005, whereas that of low HDL-cholesterol did not change substantially since 2008 (Figure 42 ). 13 Data from KNHANES 2010 showed that 14.1% of population with ≥ 30 years of age had hypercholesterolemia. Hypercholesterolemia was more prevalent in women than in men (14.9% vs. 13.4%). Until 49 years of age, the prevalence was higher in men than in women, but from 50 years hypercholesterolemia was more prevalent in women than in men ( Figure  43) . 13 In the population ≥ 60 years of age, the prevalence of hypercholesterolemia in women was more than two times higher than in men. Low HDL-cholesterol less than 40 mg/dL was observed in 26.5% of population ≥ 30 years of age, and it was A w a r e n e s s A w a r e n e s s A w a r e n e s s T r e a tm e n t T r e a tm e n t T r e a tm e n t more prevalent in men than in women for all age groups (35.8% vs. 17.4%) (Figure 44 ). The prevalence of hypertriglyceridemia ( ≥ 200 mg/dL) was higher in men than in women, and in all age groups except for people aged ≥ 70 years, hypertriglyceridemia was more prevalent in men than in women (Figure 45 ).
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Serum levels of total cholesterol, HDL-cholesterol, and triglyceride According to data from KNHANES 2010, total cholesterol level was highest in the 40-49 age group for men and 50-59 years for women. For people 19-49 years of age, total cholesterol level was higher in men than in women, but from age 50 it was higher in women than in men (Figure 46) . HDL-cholesterol level was higher in women than in men for all age groups, and triglyceride level was higher in men than in women for all age groups except for the aged ≥ 70 years ( Figure 47 ).
Awareness, treatment, and control of hypercholesterolemia
Data from KNHANES 2008-2010 showed that among peo- 13 The awareness, treatment, and control of hypercholesterolemia improved compared to data of KNHANES 2007 KNHANES -2009 , and the magnitudes of improvement were greater in women than in men (Figure 48 ). 34 Overall, women had higher percentages of awareness, treatment, and control of hypercholesterolemia than men. Younger age groups had lower percentages of awareness, treatment, and control of hypercholesterolemia than elderly groups. Among people 30-39 years of age, < 20% were aware of their hypercholesterolemia, < 10% had regular treatment, and < 3% had their cholesterol level under control (Figure 49 ).
Atrial fibrillation
There has been no representative population-based study for incidence and prevalence of atrial fibrillation in Korea. Howev- A w a r e n e s s A w a r e n e s s A w a r e n e s s T r e a tm e n t T r e a tm e n t T r e a tm e n t C o n tr o l C o n tr o l C o n tr o l 5 the projected AF prevalence in 2050 would be more than 800,000 in Korea. The prevalence of 4.0% in Korean people aged ≥ 80 years was substantially lower than that of 10% in US population of the same age. 39 Since only 1.2% (n = 175) of all examined populations were ≥ 80 years, 38 a welldesigned study that includes more elderly patients is required.
Obesity
Obesity increases blood pressure, blood glucose, blood cholesterol, and the risk of stroke.
Prevalence
Obesity in this report is defined as body mass index (BMI) ≥ 25.
One in 3 Korean adults aged ≥ 19 years is obese, an estimated 8,800,000 adults (data from 2010 KNHANES adjusted to 2005 standardized population). 13 During the period of 1998-2010, the age-standardized prevalence of obesity substantially increased in men from 21.1% to 36.3%, but slightly decreased in women from 26.2% to 24.8% (Figure 50 ). 13 Data from KNHANES 2010 showed that 31.4% of population ≥ 19 years of age were obese. Obesity was more prevalent in men than in women (36.5% vs. 26.4%). Until 59 years of age, the prevalence of obesity was higher in men than in women, but from 60 years of age, obesity was more prevalent in women than in men (Figure 51) . 13 In those less than 40 years of age, the prevalence of obesity in men was more than twice than in women.
Data from KNHANES 2010 showed that the peak prevalence of obesity differed between men and women. For women, the prevalence increased until 60-69 years of age, and then decreased. For men, the prevalence was highest in 30-39 years of age, and then generally decreased after 40 years (Figure 51 ).
According to data from KNHANES 2010, similar to obesity prevalence, BMI increased until 60-69 years of age in women and then decreased. For men, the BMI was greatest in 30-39 years and then decreased after 40 years (Figure 52 ).
Recommended physical activity
In this report, the recommended physical activity indicates a vigorous intensity of physical activity for ≥ 10 minutes at a time, ≥ 20 minutes per day, and ≥ 3 days per week, or a moderate intensity of physical activity or walk for ≥ 10 minutes at a time, ≥ 30 minutes per day, and ≥ 5 days per week.
Data from KNHANES 2010 showed that only 50% of population ≥ 19 years of age engaged in the recommended physical activity. The proportion of population who met the recommendation generally decreased during the period of 2005-2010 from 68.5% to 50.8% (Figure 53 ). For all age groups except for 40-49 Proportions of risk factors in patients with ischemic stroke or TIA in Korea
According to a nation-wide hospital-based stroke registry enrolling 46,098 patients with ischemic stroke or TIA between 2002 and 2010, HT was the most common risk factor (63.5%) followed by smoking (33.0%), DM (30.1%), prior stroke (19.7%), potential sources of cardioembolism (19.4%), and dyslipidemia (19.3%). 4 Over the nine years, the average age increased from 64.5 years to 66.7 years. The proportions of HT, DM, smoking, and prior stroke slightly but significantly decreased (for all, p for trends < 0.001), whereas the proportion of potential source of cardioembolism did not change. Trend of dyslipidemia proportions showed a complex pattern of non-directional fluctuation be- years of age, the proportions of people who met the recommended physical activity were greater in men than in women. Among women ≥ 70 year of age, less than 40% met the recommendation (Figure 54 ). 
Population attributable risk of major stroke risk factors in Korea
The relative risk (RR) is the risk of developing a disease associated with exposure to a risk factor. The RR indicates the strength of association between risk factor and disease, but it could not delineate the disease burden of the population due to the risk factor. Therefore, the population attributable risk (PAR) is usually employed for a population-based approach such as planning public health interventions. The PAR indicates the number (or proportion) of diseases (for example, strokes) that would be averted if a risk factor (for example, hypertension) is eliminated from a population. The PAR in a population depends on the prevalence of the risk factor and the strength of its association (relative risk) with the disease. For example, the RR of stroke is greater with atrial fibrillation than with smoking. However, since smoking prevalence is much greater than atrial fibrillation prevalence, the PAR of smoking is greater than that of atrial fibrillation.
To estimate the current PARs of individual risk factors in a population, contemporary population-specific prevalence and RR for each risk factor should be determined. In Korea, KNH-ANES has regularly estimated the prevalence of major cardiovascular risk factors, but cohort studies estimating RR of each risk factor for stroke have been very limited.
